Skip to main content

SOLESENCE, INC.

For the period ended Jun 30, 2026. Filed Aug 19, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 19, 2026

SLSN$0.87-3.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. Legal Proceedings

As previously disclosed, on July 6, 2026, Solésence, LLC entered into a Settlement Agreement and Release (the “Refy Settlement Agreement”) with Refy Beauty Ltd (“Refy”). Pursuant to the Refy Settlement Agreement, Solésence, LLC and Refy agreed to settle and compromise disputes relating to certain consumer care products previously sold by Solésence, LLC to Refy. Under the Refy Settlement Agreement, Solésence, LLC agreed to pay Refy the British Pound Sterling equivalent of $938,000 in twelve equal installments of $78,166.66 with the first installment due on August 5, 2026 and each subsequent payment due 30 days after the preceding payment date. The parties further agreed to a six month exclusivity period for the development of a new SPF product and potential negotiation of a new supply agreement for such SPF product. If the parties enter into such a supply agreement, the final six scheduled installment payments would instead be credited toward the purchase of the SPF product under the supply agreement.

The description of the terms and conditions of the Refy Settlement Agreement does not purport to be complete and is qualified in its entirety by the full text of the Refy Settlement Agreement, which was filed, with confidential portions redacted, as an exhibit to our Current Report on Form 8-K filed on July 10, 2026.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.